Status: Recruiting
Regulated Stimulation for Optimized Network Activity and Therapeutic Equilibrium
The objective of this study is to evaluate the safety, tolerability, and preliminary efficacy of the Motif eXternally powered Cortical Stimulation (XCS) System when used as indicated for treatment-resistant depression (TRD).
Participants needed: 20
Trial details
Age: 22-85Biological sex: AllType: InterventionalSponsor: Motif Neurotech, Inc.Updated: Sep 29, 2026Locations: 2
Eligibility criteria
Has a diagnosis of unipolar non-psychotic Major Depressive Disorder (MDD) and is... [+6]
Has a cranial implant (with the exception of dental implants), neurostimulator,... [+23]